CeriBell, Inc (CBLL) - Total Liabilities
Based on the latest financial reports, CeriBell, Inc (CBLL) has total liabilities worth $38.03 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CBLL financial resilience to evaluate the company's liquid asset resilience ratio.
CeriBell, Inc - Total Liabilities Trend (2022–2025)
This chart illustrates how CeriBell, Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CeriBell, Inc (CBLL) total assets.
CeriBell, Inc Competitors by Total Liabilities
The table below lists competitors of CeriBell, Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Oriental Jicheng Co Ltd
SHE:002819
|
China | CN¥1.51 Billion |
|
Prodea Real Estate Investment Co.
AT:PRODEA
|
Greece | €1.74 Billion |
|
Accel Entertainment Inc
NYSE:ACEL
|
USA | $794.90 Million |
|
Destiny Tech100 Inc.
NYSE:DXYZ
|
USA | $8.54 Million |
|
TOA Paint (Thailand) Public Company Limited
BK:TOA
|
Thailand | ฿6.22 Billion |
|
Cosmoam&T
KO:005070
|
Korea | ₩271.95 Billion |
|
Shenzhen Tagen Group Co Ltd
SHE:000090
|
China | CN¥42.09 Billion |
|
Middlesex Water Company
NASDAQ:MSEX
|
USA | $859.41 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down CeriBell, Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CBLL equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CeriBell, Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CeriBell, Inc (2022–2025)
The table below shows the annual total liabilities of CeriBell, Inc from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $40.47 Million | +18.16% |
| 2024-12-31 | $34.25 Million | -79.99% |
| 2023-12-31 | $171.17 Million | -0.97% |
| 2022-12-31 | $172.86 Million | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more